Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL–positive leukemic cells

Blood (2010) 116 (12): 2089–2095.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals